Review of recent literature on microneedle vaccine delivery technologies

References

• Saroja C, Lakshmi P, Bhaskaran S. Recent trends in vaccine delivery systems: a review. Int JPharm Investig. 2011;1(2):64–74.
   PubMedGoogle Scholar
• Gomez E, Zoth SC, Berinstein A. Plant-based vaccines for potential human application: a review. Hum Vaccin. 2009;5(11):738–744.
   PubMed Web of Science ®Google Scholar
• Dahlan A, Alpar HO, Stickings P, Sesardic D, Murdan S. Transcutaneous immunisation assisted by low-frequency ultrasound. Int J Pharm. 2009;368(1–2):123–128.
   PubMedGoogle Scholar
• Drabick JJ, Glasspool-Malone J, King A, Malone RW. Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther. 2001;3(2):249–255.
   PubMed Web of Science ®Google Scholar
• Mohammed AJ, AlAwaidy S, Bawikar S, et al. Fractional doses of inactivated poliovirus vaccine in Oman. N Engl J Med. 2010;362(25):2351–2359.
   PubMed Web of Science ®Google Scholar
• Dean HJ, Chen D. Epidermal powder immunization against influenza. Vaccine. 2004;23(5):681–686.
   PubMed Web of Science ®Google Scholar
• Guebre-Xabier M, Hammond SA, Epperson DE, Yu J, Ellingsworth L, Glenn GM. Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells. J Virol. 2003;77(9):5218–5225.
   PubMed Web of Science ®Google Scholar
• Frech SA, Kenney RT, Spyr CA, et al. Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine. 2005;23(7):946–950.
   PubMed Web of Science ®Google Scholar
• Frerichs DM, Ellingsworth LR, Frech SA, et al. Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch. Vaccine. 2008;26(22):2782–2787.
   PubMed Web of Science ®Google Scholar
• Kim YC, Jarrahian C, Zehrung D, Mitragotri S, Prausnitz MR. Delivery systems for intradermal vaccination. Curr Top Microbiol Immunol. 2012;351:77–112.
   PubMed Web of Science ®Google Scholar
• Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64(14):1547–1568.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Hirobe S, Okada N, Nakagawa S. Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery. Vaccine. 2013;31(19):2403–2415.
   PubMed Web of Science ®Google Scholar
• Kis EE, Winter G, Myschik J. Devices for intradermal vaccination. Vaccine. 2012;30(3):523–538.
   PubMed Web of Science ®Google Scholar
• Gerstel MS, Place VA, inventors. Drug delivery device. United States patent US3964482. June 22, 1976.
   Google Scholar
• Kang SM, Song JM, Kim YC. Microneedle and mucosal delivery of influenza vaccines. Expert Rev Vaccines. 2012;11(5):547–560.
   PubMed Web of Science ®Google Scholar
• Hutin YJ, Hauri AM, Armstrong GL. Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ. 2003;327(7423):1075.
   Google Scholar
• World Health Organization. Safety of injections: global facts and figures. 2004. Available from: http://www.who.int/injection_safety/about/resources/en/FactAndFiguresInjectionSafety.pdf. Accessed July 17, 2013.
   Google Scholar
• Debenedictis C, Joubeh S, Zhang G, Barria M, Ghohestani RF. Immune functions of the skin. Clin Dermatol. 2001;19(5):573–585.
   Web of Science ®Google Scholar
• Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol. 2004;4(3):211–222.
   PubMed Web of Science ®Google Scholar
• Belshe RB, Newman FK, Cannon J, et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med. 2004;351(22):2286–2294.
   PubMed Web of Science ®Google Scholar
• Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med. 2004;351(22):2295–2301.
   PubMed Web of Science ®Google Scholar
• Quan FS, Kim YC, Compans RW, Prausnitz MR, Kang SM. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. J Control Release. 2010;147(3):326–332.
   PubMed Web of Science ®Google Scholar
• Weldon WC, Zarnitsyn VG, Esser ES, et al. Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine. PLoS One. 2012;7(7):e41501.
   PubMed Web of Science ®Google Scholar
• Koutsonanos DG, Vassilieva EV, Stavropoulou A, et al. Delivery of subunit influenza vaccine to skin with microneedles improves immu- nogenicity and long-lived protection. SciRep. 2012;2:357.
   Google Scholar
• Wilck MB, Seaman MS, Baden LR, et al. Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration. J Infect Dis. 2010;201(9):1361–1370.
   PubMed Web of Science ®Google Scholar
• Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Release. 2010;142(2):187–195.
   PubMed Web of Science ®Google Scholar
• Kim YC, Yoo DG, Compans RW, Kang SM, Prausnitz MR. Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles. J Control Release. Epub April 30, 2013.
   Google Scholar
• Koutsonanos DG, Compans RW, Skountzou I. Targeting the skin for microneedle delivery of influenza vaccine. Adv Exp Med Biol. 2013;785:121–132.
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Weber F. Intanza 9 microg intradermal seasonal influenza vaccine for adults 18 to 59 years of age. Hum Vaccin Immunother. 2013;9(1):115–121.
   PubMed Web of Science ®Google Scholar
• Kommareddy S, Baudner BC, Bonificio A, et al. Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs. Vaccine. 2013;31(34):3435–3441.
   PubMed Web of Science ®Google Scholar
• Choi HJ, Bondy BJ, Yoo DG, Compans RW, Kang SM, Prausnitz MR. Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles. J Control Release. 2013;166(2):159–171.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Hirobe S, Yokota Y, et al. Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza. J Control Release. 2012;160(3):495–501.
   PubMed Web of Science ®Google Scholar
• del Pilar Martin M, Weldon WC, Zarnitsyn VG, et al. Local response to microneedle-based influenza immunization in the skin. MBio. 2012;3(2):e00012.
   PubMed Web of Science ®Google Scholar
• Choi HJ, Yoo DG, Bondy BJ, et al. Stability of influenza vaccine coated onto microneedles. Biomaterials. 2012;33(14):3756–3769.
   PubMed Web of Science ®Google Scholar
• Kommareddy S, Baudner BC, Oh S, Kwon SY, Singh M, O’Hagan DT. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens. J Pharm Sci. 2012;101(3):1021–1027.
   PubMed Web of Science ®Google Scholar
• Weldon WC, Martin MP, Zarnitsyn V, et al. Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity. Clin Vaccine Immunol. 2011;18(4):647–654.
   PubMed Web of Science ®Google Scholar
• Duggan ST, Plosker GL. Intanza 15 microg intradermal seasonal influenza vaccine: in older adults (aged >60 years). Drugs Aging. 2010;27(7):597–605.
   Web of Science ®Google Scholar
• Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR. Stability kinetics of influenza vaccine coated onto microneedles during drying and storage. Pharm Res. 2011;28(1):135–144.
   PubMed Web of Science ®Google Scholar
• Kim YC, Quan FS, Yoo DG, Compans RW, Kang SM, Prausnitz MR. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J Infect Dis. 2010;201(2):190–198.
   PubMed Web of Science ®Google Scholar
• Quan FS, Kim YC, Yoo DG, Compans RW, Prausnitz MR, Kang SM. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin. PLoS One. 2009;4(9):e7152.
   PubMed Web of Science ®Google Scholar
• Kim YC, Quan FS, Yoo DG, Compans RW, Kang SM, Prausnitz MR. Improved influenza vaccination in the skin using vaccine coated microneedles. Vaccine. 2009;27(49):6932–6938.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zarnitsyn VG, Ye L, et al. Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci U S A. 2009;106(19):7968–7973.
   PubMed Web of Science ®Google Scholar
• Ding Z, Verbaan FJ, Bivas-Benita M, et al. Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. J Control Release. 2009;136(1):71–78.
   PubMed Web of Science ®Google Scholar
• Koutsonanos DG, del Pilar Martin M, Zarnitsyn VG, et al. Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One. 2009;4(3):e4773.
   PubMed Web of Science ®Google Scholar
• Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine. 2009;27(3):454–459.
   PubMed Web of Science ®Google Scholar
• Alarcon JB, Hartley AW, Harvey NG, Mikszta JA. Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol. 2007;14(4):375–381.
   PubMed Web of Science ®Google Scholar
• Fernando GJ, Chen X, Prow TW, et al. Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. PLoS One. 2010;5(4):e10266.
   PubMed Web of Science ®Google Scholar
• Beran J, Ambrozaitis A, Laiskonis A, et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med. 2009;7:13.
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Vets E, Freese R, et al. Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine. 2008;26(51):6614–6619.
   PubMed Web of Science ®Google Scholar
• Holland D, Booy R, De Looze F, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis. 2008;198(5):650–658.
   PubMed Web of Science ®Google Scholar
• Arnou R, Icardi G, De Decker M, et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine. 2009;27(52):7304–7312.
   PubMed Web of Science ®Google Scholar
• Fernando GJ, Chen X, Primiero CA, et al. Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses. J Control Release. 2012;159(2):215–221.
   PubMed Web of Science ®Google Scholar
• Guo L, Chen J, Qiu Y, Zhang S, Xu B, Gao Y. Enhanced transcuta- neous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant. Int J Pharm. 2013;447(1–2):22–30.
   PubMedGoogle Scholar
• Matsuo K, Yokota Y, Zhai Y, et al. A low-invasive and effective trans- cutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens. J Control Release. 2012;161(1):10–17.
   PubMed Web of Science ®Google Scholar
• Naito S, Ito Y, Kiyohara T, Kataoka M, Ochiai M, Takada K. Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination. Vaccine. 2012;30(6):1191–1197.
   PubMed Web of Science ®Google Scholar
• Bal SM, Slutter B, Jiskoot W, Bouwstra JA. Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation. Vaccine. 2011;29(23):4025–4032.
   PubMed Web of Science ®Google Scholar
• Widera G, Johnson J, Kim L, et al. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine. 2006;24(10):1653–1664.
   PubMed Web of Science ®Google Scholar
• Kochhar JS, Zou S, Chan SY, Kang L. Protein encapsulation in polymeric microneedles by photolithography. Int J Nanomedicine. 2012;7:3143–3154.
   PubMed Web of Science ®Google Scholar
• Moon S, Wang Y, Edens C, Gentsch JR, Prausnitz MR, Jiang B. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine. 2013;31(34):3396–3402.
   PubMed Web of Science ®Google Scholar
• Pattani A, McKay PF, Garland MJ, et al. Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54 gp140 effectively primes mucosal boost inoculations. J Control Release. 2012;162(3):529–537.
   PubMed Web of Science ®Google Scholar
• Prow TW, Chen X, Prow NA, et al. Nanopatch-targeted skin vaccination against West Nile virus and Chikungunya virus in mice. Small. 2010;6(16):1776–1784.
   PubMed Web of Science ®Google Scholar
• Laurent PE, Bourhy H, Fantino M, Alchas P, Mikszta JA. Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults. Vaccine. 2010;28(36):5850–5856.
   PubMed Web of Science ®Google Scholar
• Andrianov AK, DeCollibus DP, Gillis HA, et al. Poly[di(carboxylatophenoxy) phosphazene] is a potent adjuvant for intradermal immunization. Proc Natl Acad Sci U SA. 2009;106(45):18936–18941.
   PubMed Web of Science ®Google Scholar
• Pearton M, Pirri D, Kang SM, Compans RW, Birchall JC. Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine. Adv Healthc Mater. Epub April 8, 2013.
   Google Scholar
• Song JM, Kim YC, Barlow PG, et al. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles. Antiviral Res. 2010;88(2):244–247.
   PubMed Web of Science ®Google Scholar
• Pearton M, Kang SM, Song JM, et al. Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine. 2010;28(37):6104–6113.
   PubMed Web of Science ®Google Scholar
• Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR. Formulation of microneedles coated with influenza virus-like particle vaccine. AAPS Pharm Sci Tech. 2010;11(3):1193–1201.
   PubMed Web of Science ®Google Scholar
• Song JM, Kim YC, Lipatov AS, et al. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice. Clin Vaccine Immunol. 2010;17(9):1381–1389.
   PubMedGoogle Scholar
• Quan FS, Kim YC, Vunnava A, et al. Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol. 2010;84(15):7760–7769.
   PubMed Web of Science ®Google Scholar
• Corbett HJ, Fernando GJ, Chen X, Frazer IH, Kendall MA. Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model. PLoS One. 2010;5(10):e13460.
   PubMed Web of Science ®Google Scholar
• Bachy V Hervouet C, Becker PD, et al. Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays. Proc Natl Acad Sci U S A. 2013;110(8):3041–3046.
   PubMed Web of Science ®Google Scholar
• Vrdoljak A, McGrath MG, Carey JB, et al. Coated microneedle arrays for transcutaneous delivery of live virus vaccines. J Control Release. 2012;159(1):34–42.
   PubMed Web of Science ®Google Scholar
• Carey JB, Pearson FE, Vrdoljak A, et al. Microneedle array design determines the induction of protective memory CD8+ T cell responses induced by a recombinant live malaria vaccine in mice. PLoS One. 2011;6(7):e22442.
   PubMed Web of Science ®Google Scholar
• Edens C, Collins ML, Ayers J, Rota PA, Prausnitz MR. Measles vaccination using a microneedle patch. Vaccine. 2013;31(34):3403–3409.
   PubMed Web of Science ®Google Scholar
• Dean CH, Alarcon JB, Waterston AM, et al. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. Hum Vaccin. 2005;1(3):106–111.
   PubMed Web of Science ®Google Scholar
• Hiraishi Y, Nandakumar S, Choi SO, et al. Bacillus Calmette-Guerin vaccination using a microneedle patch. Vaccine. 2011;29(14):2626–2636.
   PubMed Web of Science ®Google Scholar
• Bal SM, Ding Z, Kersten GF, Jiskoot W, Bouwstra JA. Microneedle- based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations. Pharm Res. 2010;27(9):1837–1847.
   PubMed Web of Science ®Google Scholar
• Ding Z, Bal SM, Romeijn S, Kersten GF, Jiskoot W, Bouwstra JA. Transcutaneous immunization studies in mice using diphtheria toxoid- loaded vesicle formulations and a microneedle array. Pharm Res. 2011;28(1):145–158.
   PubMed Web of Science ®Google Scholar
• Ding Z, Van Riet E, Romeijn S, Kersten GF, Jiskoot W, Bouwstra JA. Immune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB/c mice after microneedle array pretreatment. Pharm Res. 2009;26(7):1635–1643.
   PubMed Web of Science ®Google Scholar
• Morefield GL, Tammariello RF, Purcell BK, et al. An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock. J Immune Based Ther Vaccines. 2008;6:5.
   PubMedGoogle Scholar
• Huang J, D’Souza AJ, Alarcon JB, et al. Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine. Clin Vaccine Immunol. 2009;16(5):719–725.
   PubMedGoogle Scholar
• Mikszta JA, Dekker JP, III, Harvey NG, et al. Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. InfectImmun. 2006;74(12):6806–6810.
   PubMed Web of Science ®Google Scholar
• Mikszta JA, Sullivan VJ, Dean C, et al. Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. JInfect Dis. 2005;191(2):278–288.
   PubMed Web of Science ®Google Scholar
• Yin D, Liang W, Xing S, et al. Hepatitis B DNA vaccine-polycation nano-complexes enhancing immune response by percutaneous administration with microneedle. Biol Pharm Bull. Epub May 15, 2013.
   Google Scholar
• Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, Harvey NG. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med. 2002;8(4):415–419.
   PubMed Web of Science ®Google Scholar
• Gill HS, Soderholm J, Prausnitz MR, Sallberg M. Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine. Gene Ther. 2010;17(6):811–814.
   PubMed Web of Science ®Google Scholar
• Song JM, Kim YC, O EJ, Compans RW, Prausnitz MR, Kang SM. DNA vaccination in the skin using microneedles improves protection against influenza. Mol Ther. 2012;20(7):1472–1480.
   PubMed Web of Science ®Google Scholar
• Kim YC, Song JM, Lipatov AS, et al. Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch. Eur J Pharm Biopharm. 2012;81(2):239–247.
   PubMed Web of Science ®Google Scholar
• Hooper JW, Golden JW, Ferro AM, King AD. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine. 2007;25(10):1814–1823.
   PubMed Web of Science ®Google Scholar
• Chen X, Kask AS, Crichton ML, et al. Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays. J Control Release. 2010;148(3):327–333.
   PubMed Web of Science ®Google Scholar
• Kask AS, Chen X, Marshak JO, et al. DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge. Vaccine. 2010;28(47):7483–7491.
   PubMed Web of Science ®Google Scholar
• Alving CR. Design and selection of vaccine adjuvants: animal models and human trials. Vaccine. 2002;20 Suppl 3:S56-S64.
   Google Scholar
• Brennan FR, Dougan G. Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies. Vaccine. 2005;23(24):3210–3222.
   Web of Science ®Google Scholar
• Gill HS, Prausnitz MR. Coating formulations for microneedles. Pharm Res. 2007;24(7):1369–1380.
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Singh TR, Garland MJ, et al. Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery. Adv Funct Mater. 2012;22(23):4879–4890.
   PubMed Web of Science ®Google Scholar
• Maa YF, Matriano J, Ramdas A, Sellers S, inventors. Apparatus and method for transdermal delivery of influenza vaccine. World Intellectual Property Organization patent W02005099751A3. September 27, 2005.
   Google Scholar
• Matriano JA, Cormier M, Johnson J, et al. Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm Res. 2002;19(1):63–70.
   PubMed Web of Science ®Google Scholar
• Gill HS, Prausnitz MR. Coated microneedles for transdermal delivery. J Control Release. 2007;117(2):227–237.
   PubMed Web of Science ®Google Scholar
• Chen X, Prow TW, Crichton ML, et al. Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin. J Control Release. 2009;139(3):212–220.
   PubMed Web of Science ®Google Scholar
• Chen X, Fernando GJ, Crichton ML, et al. Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization. J Control Release. 2011;152(3):349–355.
   PubMed Web of Science ®Google Scholar
• Cormier M, Johnson B, Ameri M, et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. J Control Release. 2004;97(3):503–511.
   PubMed Web of Science ®Google Scholar
• McGrath MG, Vrdoljak A, O’Mahony C, Oliveira JC, Moore AC, Crean AM. Determination of parameters for successful spray coating of silicon microneedle arrays. Int J Pharm. 2011;415(1–2):140–149.
   PubMed Web of Science ®Google Scholar
• Crean A, McGrath M, Moore AC, V rdolj ak A, O’ Mahony C, inventors. Dissolvable array and spray coating method. UK patent application GB1019577.4. Nov 2010.
   Google Scholar
• Raphael AP, Prow TW, Crichton ML, Chen X, Fernando GJ, Kendall MA. Targeted, needle-free vaccinations in skin using multilayered, densely-packed dissolving microprojection arrays. Small. 2010;6(16):1785–1793.
   PubMed Web of Science ®Google Scholar
• Ng HI, Fernando GJ, Kendall MA. Induction of potent CD8(+) T cell responses through the delivery of subunit protein vaccines to skin antigen-presenting cells using densely packed microprojection arrays. J Control Release. 2012;162(3):477–484.
   PubMed Web of Science ®Google Scholar
• Malhotra R. Trials planned for pain-free, low-cost vaccine delivery. 2013. Available from: http://www.scidev.net/en/new-technologies/nanotechnology/news/trials-planned-for-pain-free-low-cost-vaccine-delivery.html. Accessed June 6, 2013.
   Google Scholar
• Harvey AJ, Kaestner SA, Sutter DE, Harvey NG, Mikszta JA, Pettis RJ. Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs. Pharm Res. 2011;28(1):107–116.
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK. Microneedle- based vaccines. Curr Top Microbiol Immunol 2009;333:369–393.
   PubMedGoogle Scholar
• Eizenberg P, Booy R, Naser N, Mason G, Stamboulian D, Weber F. Acceptance of Intanza 9 mg intradermal influenza vaccine in routine clinical practice in Australia and Argentina. Adv Ther. 2011;28(8):640–649.
   PubMed Web of Science ®Google Scholar
• Atmar RL, Patel SM, Keitel WA. Intanza: a new intradermal vaccine for seasonal influenza. Expert Rev Vaccines. 2010;9(12):1399–1409.
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Raj Singh TR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv. 2010;17(4):187–207.
   PubMed Web of Science ®Google Scholar
• Daugimont L, Baron N, Vandermeulen G, et al. Hollow microneedle arrays for intradermal drug delivery and DNA electroporation. JMembrBiol. 2010;236(1):117–125.
   PubMed Web of Science ®Google Scholar
• Park JH, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release. 2005;104(1):51–66.
   PubMed Web of Science ®Google Scholar
• Moore AC, Vrdoljak A, inventors. Method for fabricating a microneedle, and produced microneedle. World Intellectual Property Organization patent WO2012153266A2. 2012.
   Google Scholar
• Carey JB, Crean A, McGrath M, O’ Mahony C, Moore AC, V rdolj ak A, inventors. Method for fabricating a microneedle. World Intellectual Property Organization patent. W02012066506A2. May 24, 2012.
   Google Scholar
• Lee JW, Park JH, Prausnitz MR. Dissolving microneedles for transdermal drug delivery. Biomaterials. 2008;29(13):2113–2124.
   PubMed Web of Science ®Google Scholar
• McGrath MG, Vucen S, Vrdoljak A, et al. Production of dissolvable microneedles using an atomized spray process: effect of microneedle composition on skin penetration. Eur J Pharm Biopharm. Epub May 29, 2013.
   Google Scholar
• Demuth PC, Garcia-Beltran WF, Ai-Ling ML, Hammond PT, Irvine DJ. Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccination. Adv Funct Mater. 2013;23(2):161–172.
   Web of Science ®Google Scholar
• Ikejiri A, Ito Y, Naito S, Takada K. Two-and three-layered dissolving microneedles for transcutaneous delivery of model vaccine antigen in rats. J Biomater Nanobiotechnol. 2012;3:325–334.
   Google Scholar
• Sullivan SP, Koutsonanos DG, del Pilar Martin M, et al. Dissolving polymer microneedle patches for influenza vaccination. Nat Med. 2010;16(8):915–920.
   PubMed Web of Science ®Google Scholar